BRIXADI is indicated for that treatment of average to severe opioid use dysfunction in patients that have initiated treatment with an individual dose of the transmucosal buprenorphine product or service or that are currently being taken care of with buprenorphine.Those who use heroin may become tolerant on the drug. This means they can require grea… Read More